Methodenbewijsdossier

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Bronrecord

Citaten letterlijk overgenomen uit het bronrecord van de methode. Hieruit wordt geen verificatie op claimniveau afgeleid.

Adaptive Phase IV Post-Marketing Study

Taxonomisch methodendossier · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Volledige methode openen

Gecureerde claims

Claims opgeslagen in het bewijsregister, elk met zijn eigen beoordeling.

Nog geen gecureerde claims

Deze weergave verzint geen claimbeoordeling als het register er geen heeft.

Gerelateerde methoden

Gegenereerd uit de methodegraaf en getoond als machinaal voorgestelde relaties — er wordt geen bewijsclaim afgeleid.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.